| Patent Number |
Title Of Patent |
Date Issued |
| 7335370 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
February 26, 2008 |
| The present invention provides a method of immunizing a host against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method involves nucleic acid immunization, including DNA immunization, and employs a vector containing a nucleotide sequence which |
| 7326545 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
February 5, 2008 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 98 kDa outer memb |
| 7314869 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
January 1, 2008 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding OMP (outer membrane |
| 7297341 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
November 20, 2007 |
| The present invention provides purified and isolated polynucleotide molecules that encode Chlamydia polypeptides which can be used in methods to prevent, treat, and diagnose Chlamydia infection. In one form of the invention, the polynucleotide molecules are selected from DNA that encode |
| 7285276 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
October 23, 2007 |
| The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae |
| 7183402 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
February 27, 2007 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 60 kDa cysteine-rich |
| 7166289 |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
January 23, 2007 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding an inclusion membrane |
| 7118749 |
Transferrin receptor genes |
October 10, 2006 |
| Purified and isolated nucleic acid is provided which encodes a transferrin receptor protein of a strain of Haemophilus or a fragment or an analog of the transferrin receptor protein. The nucleic acid sequence may be used to produce peptides free of contaminants derived from bacteria norm |
| 7081245 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
July 25, 2006 |
| The present invention provides nucleic acids, proteins and vectors for a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method employs a vector containing a |
| 7070792 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
July 4, 2006 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding full-length, 5'-tru |
| 7026300 |
One step immunization procedure for inducing a Chlamydia specific immune response |
April 11, 2006 |
| A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to |
| 7019125 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
March 28, 2006 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding an omp P6 precursor of |
| 6872814 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
March 29, 2005 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6811783 |
Immunogenic compositions for protection against chlamydial infection |
November 2, 2004 |
| A protective immune response against Chlamydial infection is achieved by in vivo administration of an immunogenic composition comprising two vectors and a pharmaceutically-acceptable carrier therefor. One of the vectors comprises a first nucleotide sequence encoding a major outer membran |
| 6808713 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
October 26, 2004 |
| The present invention provides a method of immunizing a host against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method involves nucleic acid immunization, including DNA immunization, and employs a vector containing a nucleotide sequence which |
| 6693087 |
Nucleic acid molecules encoding POMP91A protein of Chlamydia |
February 17, 2004 |
| An isolated and purified nucleic acid molecule encoding a POMP91A protein of a strain of Chlamydia, is useful for nucleic acid immunization of a host, including a human host, against disease caused by infection by a strain of Chlamydia, particularly C. pneumoniae. |
| 6686339 |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
February 3, 2004 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6676949 |
Two-step immunization procedure against Chlamydia infection |
January 13, 2004 |
| A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to be |
| 6660275 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
December 9, 2003 |
| The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding a CPN100605 polype |
| 6649370 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
November 18, 2003 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6642025 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
November 4, 2003 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6635746 |
Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and method |
October 21, 2003 |
| Immunogenic compositions including vaccines are described that comprise an outer membrane antigen extract of a strain of Chlamydia and are effective in protection against disease caused by Chlamydia infection The immunogenic compositions may comprise the major outer membrane protein |
| 6607730 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
August 19, 2003 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6521745 |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
February 18, 2003 |
| An isolated and purified nucleic acid molecule encoding an inclusion membrane protein C of a strain of Chlamydia, is useful for nucleic acid immunization of a host, including a human host, against disease caused by infection by a strain of Chlamydia, particularly C. pneumoniae. |
| 6464979 |
Chlamydial vaccines and methods of preparation thereof |
October 15, 2002 |
| Immunogenic compositions including vaccines are described that comprise an outer membrane antigen extract of a strain of Chlamydia and are effective in protection against disease caused by Chlamydia infection. The immunogenic compositions may comprise the major outer membrane protein |
| 6403102 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
June 11, 2002 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6403101 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
June 11, 2002 |
| In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence |
| 6361779 |
Transferrin receptor genes |
March 26, 2002 |
| Purified and isolated nucleic acid is provided which encodes a transferrin receptor protein of a strain of Haemophilus or a fragment or an analog of the transferrin receptor protein. The nucleic acid sequence may be used to produce peptides free of contaminants derived from bacteria norm |
| 6358727 |
Haemophilus transferrin receptor genes |
March 19, 2002 |
| Purified and isolated nucleic acid is provided which encodes a transferrin receptor protein of a strain of Haemophilus or a fragment or an analog of the transferrin receptor protein. The nucleic acid sequence may be used to produce peptides free of contaminants derived from bacteria norm |
| 6156538 |
Heterologous gene expression with poliovirus replicon |
December 5, 2000 |
| The replication machinery of polio virus is used to express heterologous gene products, such as chloramphenicol acetyl transferase, in mammalian cells. Detectable expression following DNA transfection demonstrated that a polio replicon containing a foreign gene in the P1 region transcrib |
